Most genomic alterations are tolerated while only a minor fraction disrupts molecular 27 function sufficiently to drive disease. Protein kinases play a central biological 28 function and the functional consequences of their variants are abundantly 29 characterized. However, this heterogeneous information is often scattered across 30 different sources, which makes the integrative analysis complex and laborious. 
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INTRODUCTION 50
Only a minor fraction of the large number of variants discovered with current high-51
Datasets and data pre-processing 123
In the present work we used publicly available datasets: (1) UniProt Variant Pages 124 (Yip et al. 2008 ), (2) KinMutBase (Ortutay et al. 2005) , (3) Kin-Driver (Simonetti et 125 al. 2014 ), (4) COSMIC (Bamford et al. 2004) , and (5) ClinVar (Landrum et al. 2014) . 126
We decided to use all variants for which a classification as neutral/disease was 127 available in UniProt Variant Pages. No filtering based on the disease that might have 128 originated the classification was exerted. A total of 850 variants affecting 299 kinases 129
were not used in the analysis because they were listed as unclassified in UniProt. 
Data availability and reproducibility of results 140
The datasets utilised for training and evaluation of KinMutRF, included the data 141 splits in the 10-fold cross-validation, are available through the help pages of our web 142 server. The selected 3689 variants described in the previous section were randomly 143 divided into 10 bins of similar sizes, constrained only by the rule that different 144 variants affecting the same protein should be forced into the same bin. We 145 incorporated this rule to avoid overestimating the performance of the classification 146 due to similarities between elements of the training and evaluation sets. 147
For each dataset, we compiled tab-separated files containing the classification 148 features. To assess the contribution of individual features we calculated their 149 information gain with respect to the classification classes using the 150
InfoGainAttributeEval function in Weka. More details about identification of the most 151 relevant features for prediction (see Supp. Table S2 ), and evaluation of KinMutRF's 152 performance according to external datasets are provided in Supplementary Materials. 153
RESULTS
154
Interpretation of the consequences of variants 155
By default, wKinMut-2 presents a 'Summary table' that provides a quick overview 156 pathogenicity scores according to our kinase-specific random forest-based predictor. 167
Further details will be provided in the corresponding section. Note that a summaryreport of the prediction and all relevant files for the prediction are available for direct 169 download from this page. 170
The primary goal of wKinMut-2 is to aid computational biologists and clinicians to 171 understand and to interpret the consequences of disease-causing variants acquired by 172 human protein kinases. Expanded information is gathered and provided when the user 173 clicks on the 'View details' button (Supp. Fig. S1, panel b) . This spawns a multi-174 tabular page including the characterization of the variants at the protein, domain and 175 residue level; the representation of the variants onto known protein structures and 176 models including the analysis of the disruption of the protein-protein interaction 177 interfaces; the prediction of pathogenicity using different methodologies; the 178 collection of mentions of the variants in dedicated knowledgebases, complemented 179 with information mined from the literature and the study of the known and predicted 180 interaction partners. Each of these tabs will be detailed in the following sections and 181 their main characteristics explained. 182
General description of the mutated kinases 183
The first view presents a 'General' tab (Supp. Table S3 . 244
In the following sections we will discuss how the combination of prediction of 245 pathogenicity and integration of information can enhance our understanding of the 246 consequences of variants and facilitate the generation of working hypotheses. 
Mining of variants from the literature 288
Mining the literature complements the information sourced from the databases. A 289 substantial number of references describe the experimental conditions or the specific 290 background of the patients. Furthermore, in some cases the mined articles may 291 describe the biochemical mechanisms by which variants might lead to the 292 corresponding diseases. As these aspects are essential for the correct interpretation of 293 the consequences of variation, wKinMut-2 collects mentions to kinase variants from 294 the literature using SNP2L (Krallinger et al. 2009 ). Our literature-mining pipeline 295 extracts and disambiguates automatically references to variants in both PubMed 296 abstracts and full text articles. Strict internal filters increase the reliability of SNP2L; 297 after variation mentions and kinases have been identified in a text, SNP2L checks the 298 coherence of the mined amino acids and the expected sequences to reduce the number 299 of spurious hits. SNP2L results are displayed under the 'Literature' tab of wKinMut-2 300 (Supp. Fig. S1, panel h) . 301
Identification of interaction partners 302
Two methods are used for the exploration of protein-protein interactions. First, the 303 'iHop' tab (Supp. sentences from the literature as well as pointers to the original articles. Secondly, the 308 'String' tab (Supp. Fig. S1 , panel j) graphically shows the interactions described for 309 the human kinome in the homonymous database (Szklarczyk et al. 2015) . Evidence 310 for interactions include gene neighborhood and gene fusion events, co-occurrence of 311 the proteins across species, co-expression of genes in the same or other related 312 species, experiments stored in databases as well as text-mining of PubMed abstracts. 313
USE CASES 314
To illustrate the utility of wKinMut-2, we describe next two examples where the 315 system is used to draw hypotheses about the role of kinase variants in the onset of 316 human diseases. 317
The p.V600E variant in the B-Raf proto-oncogene. 318
The B-Raf proto-oncogene is involved in the transduction of the mitogenic signals 319 from the cell to the membrane of the nucleus. As described in the 'General' tab of 320 
